Adamant Biomedical Investments AG
CIK 1542336
13F portfolio (2014-Q4)
$418M
Positions
101
As reported on this filer's Form 13F for 2014-Q4, filed 2015-02-13. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | — | CELGENE CORP |
| 2 | BIIB | BIOGEN INC |
| 3 | GILD | GILEAD SCIENCES INC |
| 4 | AMGN | AMGEN INC |
| 5 | — | ACTAVIS PLC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →